Invitation to presentation BioArctic invites investors, analysts and media to an audiocast with teleconference (in English) today, November 13, at 9:30–10:30 a.m. CET. CEO Gunilla Osswald and CFO ...

Few primary care practices are designed for the timely detection of Alzheimer's disease and related dementias. The limited ...

The past two decades have seen major advances in Alzheimer's disease research and clinical care, catalysed by the development of CSF and blood biomarkers and PET imaging that reliably detect amyloid β ...

Mayo Clinic researchers have developed a new tool that can estimate a person's risk of developing memory and thinking ...

A study published Wednesday reports "significant" disparities in the risk of dementia for lower income and non-white ...

A team of researchers at the Federal University of ABC (UFABC) in Brazil has developed a new chemical compound with the ...

Researchers found that lecanemab, the Alzheimer’s drug designed to clear amyloid-β plaques, does not improve the brain’s waste clearance system in the short term.

Israel's president says authorities must take decisive action to stop “shocking and serious” Jewish settler violence against ...

The 2025 Walk to End Alzheimer’s New River Valley raised a whopping $75,000 to support the fight against Alzheimer’s Disease.

Boosting a natural molecule that fuels cellular repair helps brain cells stay organized - a change that may slow memory loss.

At 73, Robert Fishman reflects on caring for his 97-year-old mom with dementia, using his art to confront memory loss and ...